1. Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study. (October 2021) Authors: Bhushan B L, Shashi; Wanve, Sunil; Koradia, Parshottam; Bhomia, Vinay; Soni, Pravin; Chakraborty, Sisir; Khobragade, Akash; Joshi, Shashank; Mendiratta, Sanjeev Kumar; Kansagra, Kevin Kumar; Parihar, Anurag; Sharma, Sunil; Patel, Jatin Journal: International journal of infectious diseases Issue: Volume 111(2021) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India. Issue 10332 (2nd April 2022) Authors: Khobragade, Akash; Bhate, Suresh; Ramaiah, Vijendra; Deshpande, Shrikant; Giri, Krishna; Phophle, Himanshu; Supe, Pravin; Godara, Inderjeet; Revanna, Ramesh; Nagarkar, Rajnish; Sanmukhani, Jayesh; Dey, Ayan; Rajanathan, T M Chozhavel; Kansagra, Kevinkumar; Koradia, Parshottam Journal: Lancet Issue: Volume 399:Issue 10332(2022) Page Start: 1313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study. Issue 11 (2nd November 2021) Authors: H S, Ravish; Khobragade, Akash; Satapathy, Durga; Gupta, Monica; Kumar, Surendra; Bhomia, Vinay; V, Ramasubramanian; Desai, Maharshi; Agrawal, Ashok Dilipkumar Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 11(2021) Page Start: 4239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗